4//SEC Filing
Simon Farrell 4
Accession 0001209191-23-017148
CIK 0001563880other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:00 PM ET
Size
7.1 KB
Accession
0001209191-23-017148
Insider Transaction Report
Form 4
Simon Farrell
Chief Commercial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-03-07−18,750→ 56,250 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (18,750 underlying) - Exercise/Conversion
Common Stock
2023-03-07$0.51/sh+18,750$9,581→ 39,400 total
Footnotes (1)
- [F1]This option was granted on February 11, 2022. The 75,000 shares of common stock underlying the option vested as to 25% of the shares on February 11, 2023 and vest as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001965585
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:00 PM ET
- Size
- 7.1 KB